Buy-side “Head of M&A as a Service” for Belgian MedTech innovator QbD Group

The right M&A freelancer for a MedTech buy-side project? No problem.


QbD Group, a life science consultancy and software leader active in the development, clinical, regulatory & compliance, production and distribution for companies active in ATMP, Biotech, Medical Devices, In Vitro Diagnostics, Digital Health and Pharma, has a clear roadmap for inorganic growth.

The company from Wilrijk, Belgium, has almost 500 full-time employees and operates worldwide. While they previously worked with established local partners, they wanted to switch to a faster, global approach. That’s when they found out about Fintalent.




Fintalent delivered an experienced M&A leader with relevant industry experience. The contract was signed within 2 weeks.

The goal was to deliver a long- and shortlist of potential acquisition targets.


6 weeks after the first contact with Fintalent, QbD Group started leading the first conversations with potential targets, and are very optimistic about the outcome of the project.

»From first contact to project start took us only two weeks. Now, we’re already talking to potential targets!«

Bart van Acker, CEO, QbD Group